4
Changes in Ownership
RESMED INC Filed Acc 0001127602-25-009051
Chief Commercial Officer, SaaS sold 9,745 shares at $239.31 ($2,332,096)
- Chief Commercial Officer, SaaS acquired 9,745 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Ghoshal Kaushik · Chief Commercial Officer, SaaS
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-10 | Exercise or conversion : show line 1 in the form 10b5-1 | +169 | $146.34 | $24,731 | 9,894 | D |
| 2025-03-10 | Exercise or conversion : show line 2 in the form 10b5-1 | +105 | $211.76 | $22,235 | 9,999 | D |
| 2025-03-10 | Exercise or conversion : show line 3 in the form 10b5-1 | +3,589 | $146.34 | $525,214 | 13,588 | D |
| 2025-03-10 | Exercise or conversion : show line 4 in the form 10b5-1 | +5,882 | $211.76 | $1,245,572 | 19,470 | D |
| 2025-03-10 | Sale : show line 5 in the form 10b5-1 | −9,745 | $239.31 | $2,332,096 | 9,725 | D |
| Open-market sales · 9,745 sh · avg $239.31 · $2,332,096 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-03-10 | Exercise or conversion : show line 6 in the form 10b5-1 ResMed Common Stock Options | −169 | 0 | D |
| 2025-03-10 | Exercise or conversion : show line 7 in the form 10b5-1 ResMed Common Stock Options | −105 | 0 | D |
| 2025-03-10 | Exercise or conversion : show line 8 in the form 10b5-1 ResMed Common Stock Options | −5,882 | 0 | D |
| 2025-03-10 | Exercise or conversion : show line 9 in the form 10b5-1 ResMed Common Stock Options | −3,589 | 0 | D |
Loading xslF345X05/form4.xml…